304 related articles for article (PubMed ID: 24089515)
1. Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes.
van Lummel M; Duinkerken G; van Veelen PA; de Ru A; Cordfunke R; Zaldumbide A; Gomez-Touriño I; Arif S; Peakman M; Drijfhout JW; Roep BO
Diabetes; 2014 Jan; 63(1):237-47. PubMed ID: 24089515
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.
van Lummel M; van Veelen PA; de Ru AH; Pool J; Nikolic T; Laban S; Joosten A; Drijfhout JW; Gómez-Touriño I; Arif S; Aanstoot HJ; Peakman M; Roep BO
Diabetes; 2016 Mar; 65(3):732-41. PubMed ID: 26718497
[TBL] [Abstract][Full Text] [Related]
3. Human islets and dendritic cells generate post-translationally modified islet autoantigens.
McLaughlin RJ; de Haan A; Zaldumbide A; de Koning EJ; de Ru AH; van Veelen PA; van Lummel M; Roep BO
Clin Exp Immunol; 2016 Aug; 185(2):133-40. PubMed ID: 26861694
[TBL] [Abstract][Full Text] [Related]
4. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
[TBL] [Abstract][Full Text] [Related]
5. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens.
Honeyman MC; Stone NL; Falk BA; Nepom G; Harrison LC
J Immunol; 2010 Feb; 184(4):2204-10. PubMed ID: 20083660
[TBL] [Abstract][Full Text] [Related]
6. Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes.
Harfouch-Hammoud E; Walk T; Otto H; Jung G; Bach JF; van Endert PM; Caillat-Zucman S
Diabetes; 1999 Oct; 48(10):1937-47. PubMed ID: 10512357
[TBL] [Abstract][Full Text] [Related]
7. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
[TBL] [Abstract][Full Text] [Related]
8. Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.
Ge X; James EA; Reijonen H; Kwok WW
J Autoimmun; 2011 Mar; 36(2):155-60. PubMed ID: 21257290
[TBL] [Abstract][Full Text] [Related]
9. Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.
So M; Elso CM; Tresoldi E; Pakusch M; Pathiraja V; Wentworth JM; Harrison LC; Krishnamurthy B; Thomas HE; Rodda C; Cameron FJ; McMahon J; Kay TWH; Mannering SI
Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10732-10737. PubMed ID: 30275329
[TBL] [Abstract][Full Text] [Related]
10. Changing faces, unmasking the beta-cell: post-translational modification of antigens in type 1 diabetes.
van Lummel M; Zaldumbide A; Roep BO
Curr Opin Endocrinol Diabetes Obes; 2013 Aug; 20(4):299-306. PubMed ID: 23770733
[TBL] [Abstract][Full Text] [Related]
11. Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire.
van Lummel M; van Veelen PA; Zaldumbide A; de Ru A; Janssen GM; Moustakas AK; Papadopoulos GK; Drijfhout JW; Roep BO; Koning F
J Biol Chem; 2012 Mar; 287(12):9514-24. PubMed ID: 22184118
[TBL] [Abstract][Full Text] [Related]
12. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes.
Pathiraja V; Kuehlich JP; Campbell PD; Krishnamurthy B; Loudovaris T; Coates PT; Brodnicki TC; O'Connell PJ; Kedzierska K; Rodda C; Bergman P; Hill E; Purcell AW; Dudek NL; Thomas HE; Kay TW; Mannering SI
Diabetes; 2015 Jan; 64(1):172-82. PubMed ID: 25157096
[TBL] [Abstract][Full Text] [Related]
13. Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.
Zhou Z; Reyes-Vargas E; Escobar H; Rudd B; Rockwood AL; Delgado JC; He X; Jensen PE
Eur J Immunol; 2016 Apr; 46(4):834-45. PubMed ID: 26707565
[TBL] [Abstract][Full Text] [Related]
14. Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1*06 alleles.
Ettinger RA; Papadopoulos GK; Moustakas AK; Nepom GT; Kwok WW
J Immunol; 2006 Feb; 176(3):1988-98. PubMed ID: 16424231
[TBL] [Abstract][Full Text] [Related]
15. A molecule's right to choose: how diabetogenic class II MHC products bind peptides.
Ploegh HL
J Clin Invest; 2005 Aug; 115(8):2077-9. PubMed ID: 16075053
[TBL] [Abstract][Full Text] [Related]
16. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
Babon JA; DeNicola ME; Blodgett DM; Crèvecoeur I; Buttrick TS; Maehr R; Bottino R; Naji A; Kaddis J; Elyaman W; James EA; Haliyur R; Brissova M; Overbergh L; Mathieu C; Delong T; Haskins K; Pugliese A; Campbell-Thompson M; Mathews C; Atkinson MA; Powers AC; Harlan DM; Kent SC
Nat Med; 2016 Dec; 22(12):1482-1487. PubMed ID: 27798614
[TBL] [Abstract][Full Text] [Related]
17. Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects.
Nakayama M; McDaniel K; Fitzgerald-Miller L; Kiekhaefer C; Snell-Bergeon JK; Davidson HW; Rewers M; Yu L; Gottlieb P; Kappler JW; Michels A
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4429-34. PubMed ID: 25831495
[TBL] [Abstract][Full Text] [Related]
18. Epitopes recognized by CBV4 responding T cells: effect of type 1 diabetes and associated HLA-DR-DQ haplotypes.
Marttila J; Hyöty H; Näntö-Salonen K; Simell O; Ilonen J
Virology; 2004 Feb; 319(1):27-35. PubMed ID: 14967485
[TBL] [Abstract][Full Text] [Related]
19. Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules.
Astill TP; Ellis RJ; Arif S; Tree TI; Peakman M
Diabetologia; 2003 Apr; 46(4):496-503. PubMed ID: 12684749
[TBL] [Abstract][Full Text] [Related]
20. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
Lohmann T; Halder T; Engler J; Morgenthaler NG; Khoo-Morgenthaler UY; Schröder S; Seissler J; Scherbaum WA; Kalbacher H
Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
